2022 Annual Meeting | C7 - Neuroendocrine Update: Nuts and Bolts of What You Need to Know

Date Saturday 04/02/22

Time 07:00 AM - 09:00 AM PDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Alison M. Pack, MD, FAAN

Topic(s) General Neurology

Learning Objectives Participants should be able to understand how neuroendocrine anatomy and humoral relationships influence the presentation and treatment of epilepsy, Parkinson's disease, aging, and dementia, as well as understand the impact of neuroendocrine system on neurocritical care.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement, Systems-based Practice

Program Level Introductory

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student

Teaching Styles Didactic

Program Materials Program Evaluations

Event Timeline
07:00 AM - 07:05 AM PDT	Introduction	Introduction Alison M. Pack, MD, FAAN
07:00 AM - 09:00 AM PDT	Speaker	walk in slides Alison M. Pack, MD, FAAN
07:05 AM - 07:30 AM PDT	Speaker	Neuroendocrine Axes: Hypothalamus, Pituitary, and Beyond Karen K. Miller, MD
07:30 AM - 07:55 AM PDT	Speaker	Epilepsy, Antiepileptic Drugs, and Neuroendocrine Effects Alison M. Pack, MD, FAAN
07:55 AM - 08:20 AM PDT	Speaker	Neuroendocrine Aspects of Cognitive Aging and Dementia Victor W. Henderson, MD, FAAN
08:20 AM - 08:45 AM PDT	Speaker	Neurocritical Care and Neuroendocrinology: An Overview Torrey B. Birch, MD
08:45 AM - 09:00 AM PDT	Q&A	Questions and Answers Alison M. Pack, MD, FAAN, Victor W. Henderson, MD, FAAN, Torrey B. Birch, MD, Karen K. Miller, MD

Faculty Disclosures
Alison M. Pack, MD, FAAN	An immediate family member of Dr. Pack has received personal compensation for serving as an employee of REGENEXBIO. The institution of Dr. Pack has received research support from National Institutes of Health. Dr. Pack has received publishing royalties from a publication relating to health care.
Karen K. Miller, MD	Dr. Klahr Miller has stock in Amgen. Dr. Klahr Miller has stock in Bristol-Myers Squibb . Dr. Klahr Miller has stock in GE. Dr. Klahr Miller has stock in Boston Scientific. Dr. Klahr Miller has stock in Becton Dickinson. An immediate family member of Dr. Klahr Miller has stock in Bristol-Myers Squibb . An immediate family member of Dr. Klahr Miller has stock in GE. An immediate family member of Dr. Klahr Miller has stock in Boston Scientific. An immediate family member of Dr. Klahr Miller has stock in Bristol-Myers Squibb . The institution of Dr. Klahr Miller has received research support from Amgen. The institution of Dr. Klahr Miller has received research support from Pfizer. Dr. Klahr Miller has received publishing royalties from a publication relating to health care.
Victor W. Henderson, MD, FAAN	Dr. Henderson has stock in Abbott, Amgen, Roche. The institution of Dr. Henderson has received research support from NIH. The institution of Dr. Henderson has received research support from Health IQ. Dr. Henderson has received personal compensation in the range of $500-$4,999 for serving as a External advisory committee member, Alzheimer's Disease Center with University of Kansas. Dr. Henderson has a non-compensated relationship as a adjunct (honorary) professor with Aarhus University that is relevant to AAN interests or activities.
Torrey B. Birch, MD	Dr. Birch has nothing to disclose.